ERIS LIFESCIENCES
Back to Cashflow Statement
|
ERIS LIFESCIENCES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-314 Cr | ₹-881 Cr | ₹1,380 Cr | ₹688 Cr | ₹-45 Cr |
What is the latest Cash Flow from Financing Activities ratio of ERIS LIFESCIENCES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-314 Cr |
| Mar2025 | ₹-881 Cr |
| Mar2024 | ₹1,380 Cr |
| Mar2023 | ₹688 Cr |
| Mar2022 | ₹-45 Cr |
How is Cash Flow from Financing Activities of ERIS LIFESCIENCES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-314 Cr | Negative | |
| Mar2025 | ₹-881 Cr | Negative | |
| Mar2024 | ₹1,380 Cr | 100.53 | |
| Mar2023 | ₹688 Cr | Positive | |
| Mar2022 | ₹-45 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹18,162.1 Cr | 4.6% | 14% | -19.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,291.0 Cr | -1.8% | 7.6% | 11.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹305,014.0 Cr | 3.7% | 27.2% | 71.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,333.0 Cr | -2.3% | 1.5% | 23.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,017.0 Cr | 0.6% | 13.4% | 15.7% | Stock Analytics | |
| CIPLA | ₹112,539.0 Cr | -1.3% | 6.1% | -6.9% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | 4.6% |
14% |
-19.9% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses